ANNALS OF PLASTIC SURGERY, cilt.77, sa.5, ss.560-568, 2016 (SCI-Expanded)
Background: Autogenous bone grafts are still the criterion standard treatment option in critical-size bone defect reconstructions, and many therapies can affect its incorporation. In this study, it was aimed to research the effects of desferroxamine (DFO) application on bone and bone graft healing due to the effects of osteoblast and osteoclast regulation and stimulation of angiogenesis.